Wolverine Trading’s Varian Medical Systems, Inc. VAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,400
Closed -$530K 5447
2020
Q2
$530K Hold
4,400
﹤0.01% 2674
2020
Q1
$456K Sell
4,400
-2,700
-38% -$357K ﹤0.01% 2762
2019
Q4
$1M Sell
7,100
-10,900
-61% -$1.39M ﹤0.01% 2408
2019
Q3
$2.13M Buy
18,000
+4,400
+32% +$523K 0.01% 1394
2019
Q2
$1.85M Sell
13,600
-4,400
-24% -$588K 0.01% 1564
2019
Q1
$2.55M Sell
18,000
-4,400
-20% -$578K 0.01% 1335
2018
Q4
$2.51M Buy
22,400
+10,600
+90% +$1.21M 0.01% 1252
2018
Q3
$1.32M Buy
11,800
+5,500
+87% +$622K ﹤0.01% 2049
2018
Q2
$773K Hold
6,300
﹤0.01% 2543
2018
Q1
$773K Sell
6,300
-1,400
-18% -$167K ﹤0.01% 2543
2017
Q4
$856K Buy
+7,700
New +$828K ﹤0.01% 2390
2017
Q2
Sell
-3,600
Closed -$328K 5226
2017
Q1
$328K Sell
3,600
-5,181
-59% -$432K ﹤0.01% 2920
2016
Q4
$691K Buy
8,781
+3,763
+75% +$304K ﹤0.01% 2270
2016
Q3
$434K Buy
5,018
+571
+13% +$46.6K ﹤0.01% 2752
2016
Q2
$314K Buy
+4,447
New +$322K ﹤0.01% 2748

Other funds holding VAR

Wolverine Trading's VAR Position: Q3 2020 in Review

Wolverine Trading sold out of Varian Medical Systems, Inc. (VAR) in Q3 2020, closing a stake of 3,612 shares — an estimated $435K sold.

Wolverine Trading first reported a position in VAR in Q2 2016 and held it in 10 quarters. The position peaked at $1.45M in Q4 2018. 642 funds tracked by Wall St. Rank hold VAR as of Q3 2020.

  • Wolverine Trading reported no remaining Varian Medical Systems, Inc. position as of Q3 2020 after selling out during the quarter.
  • Wolverine Trading sold 3,612 Varian Medical Systems, Inc. shares in Q3 2020, an estimated $435K.
  • Wolverine Trading first reported a position in Varian Medical Systems, Inc. in Q2 2016 and held it in 10 quarters.
  • Wolverine Trading's Varian Medical Systems, Inc. position peaked at $1.45M in Q4 2018.
  • 642 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q3 2020.

Based on Wolverine Trading's 13F filing for Q3 2020, filed 13 Nov 2020.